These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31285829)

  • 1. Phosphorus Consumption Within 1 Hour Prior to Blood Work and Associated Serum Levels of Phosphate, Calcium, and PTH in Adult Patients Receiving Hemodialysis Treatment.
    Mazzetti T; Hopman WM; Couture L; Christilaw E; Munroe J; Babiolakis CS; Adams MA; Holden RM
    Can J Kidney Health Dis; 2019; 6():2054358119856891. PubMed ID: 31285829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary interventions for mineral and bone disorder in people with chronic kidney disease.
    Liu Z; Su G; Guo X; Wu Y; Liu X; Zou C; Zhang L; Yang Q; Xu Y; Ma W
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010350. PubMed ID: 26376110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients.
    Karaboyas A; Muenz D; Fuller DS; Desai P; Lin TC; Robinson BM; Rossetti S; Pisoni RL
    Am J Kidney Dis; 2022 Mar; 79(3):362-373. PubMed ID: 34273436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineral bone disorder and its management among hemodialysis patients in the Gulf Cooperation Council: Initial findings from the dialysis outcomes and practice patterns study (2012-2015).
    Al Salmi I; AlRukhaimi M; AlSahow A; Shaheen FA; Al-Ghamdi SM; AlAli F; AlGhareeb S; Al Maimani Y; AlGhonaim M; Bieber B; Tentori F; Pisoni RL;
    Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):62-80. PubMed ID: 27991480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid Load and Phosphorus Homeostasis in CKD.
    Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
    Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism.
    Soohoo M; Obi Y; Rivara MB; Adams SV; Lau WL; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Arah OA; Mehrotra R; Streja E
    Am J Nephrol; 2022; 53(2-3):157-168. PubMed ID: 35226895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: a cross-sectional study on healthy premenopausal women.
    Kemi VE; Rita HJ; Kärkkäinen MU; Viljakainen HT; Laaksonen MM; Outila TA; Lamberg-Allardt CJ
    Public Health Nutr; 2009 Oct; 12(10):1885-92. PubMed ID: 19216809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hidden and complex relationship between dietary phosphorus and malnutrition in hemodialysis patients with chronic kidney disease.
    Milla C; Widodo ; Wardhana TH
    Rom J Intern Med; 2024 Mar; 62(1):52-60. PubMed ID: 37991505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.
    Block GA; Hulbert-Shearon TE; Levin NW; Port FK
    Am J Kidney Dis; 1998 Apr; 31(4):607-17. PubMed ID: 9531176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
    Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
    Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
    Wang M; Obi Y; Streja E; Rhee CM; Lau WL; Chen J; Hao C; Hamano T; Kovesdy CP; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1118-1127. PubMed ID: 28487345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein intake, control of serum phosphorus, and relatively low levels of parathyroid hormone in elderly hemodialysis patients.
    Lorenzo V; Martín M; Rufino M; Jiménez A; Malo AM; Sanchez E; Hernández D; Rodríguez M; Torres A
    Am J Kidney Dis; 2001 Jun; 37(6):1260-6. PubMed ID: 11382697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
    Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Phosphate and the Forgotten Kidney Patient: A Critical Need for FDA Regulatory Action.
    Calvo MS; Sherman RA; Uribarri J
    Am J Kidney Dis; 2019 Apr; 73(4):542-551. PubMed ID: 30686528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study.
    Chen L; Tang X; Zheng H; Wang H; Xia P; Wang Y; Zhao X; Zhou Z; Qiu L; Li X
    Ren Fail; 2022 Dec; 44(1):336-345. PubMed ID: 35380083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.